UC-II Collagen Research Highlighted at Scripps Conference

BENICIA, Calif.InterHealth Nutraceuticals earned first place honors at the 2013 Scripps Natural Supplement Conference for its new research on UC-II®, an undenatured type 2 collagen ingredient for joint health. The company presented a new randomized, double blind, placebo-controlled study, which found UC-II significantly improved knee joint flexibility compared to placebo. Supplementation also delayed the onset of joint pain when exercising (via stepmill), and accelerated the offset of joint discomfort after exercising compared to baseline. The study used 55 healthy subjects who did not meet the American College of Rheumatology criteria for osteoarthritis for 17 weeks.

Principal researcher, Jay Udani, M.D., CEO of Medicus Research, presented the results at the Scripps conference in San Diego, Jan. 31 to Feb. 2, 2013. Investigators for the trial noted, "Supplementation with UC-II for 17 weeks was well-tolerated and more effective than placebo in supporting joint comfort, flexibility and mobility." Udani also presented the "Weight Loss Clinical Trial"  poster, which won second place.

The abstract will be published in an upcoming issue of  the Journal of Alternative and Complementary Medicine.

Interested in learning more about joint health ingredients such as type 2 collagen? Visit INSIDER's Joint Health Content Library.